Biotech News
Filter News
Found 601,069 articles
-
What is the best way to prevent or even reverse Alzheimer’s disease? That’s the question at the top of many researchers’ minds, especially given all of the recent large Phase 3 failures involving beta-amyloid targeting drugs, the most pursued target to date. This is troubling but not entirely sho...
-
Although still preliminary, Regeneron Pharmaceuticals announced early data from its Phase I/II/III trial of its antibody cocktail, REGN-COV2, against COVID-19.
-
The special purpose acquisition company, which has listed the units and is beginning to trade on the Nasdaq Capital Market, expects the proposed deal to command a market value of close to $500 million.
-
Catalyst Pharmaceuticals is reeling this morning after a federal judge dismissed the company’s lawsuit against the U.S. Food and Drug Administration regarding the approval of a rival drug for a rare autoimmune disease from New Jersey-based Jacobus Pharmaceutical.
-
Moderna published second interim analysis of its open-label Phase I trial of its COVID-19 vaccine, mRNA-1273, in The New England Journal of Medicine.
-
Pfizer invested $200 million into the company for a nearly 10% stake to support the development of a checkpoint inhibitor aimed at the oncology market in China.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 30, 2020.
-
New Collab Boosts Serum Institute of India’s COVID-19 Vaccine Production by 100 Million Doses
9/30/2020
The Serum Institute of India (SII) has agreed to produce and deliver up to an additional 100 million doses of an approved COVID-19 vaccine for citizens of India and neighboring low- and middle-income countries as part of a collaboration with Gavi and the Bill & Melinda Gates Foundation. -
Draper’s Tumor-on-a-Chip Parallels In Vivo Findings of Checkpoint Inhibitor Efficacy in Mice
9/30/2020
Draper, in one of the latest lab-on-a-chip advances, has shown that its dynamic, in vitro tumor microenvironment can be used to distinguish tumor responses against two different checkpoint inhibitors in three mouse lines. -
California Gov. Gavin Newsom signed Senate Bill 852 into law on Monday, paving the way for California to manufacture cheaper versions of insulin and other drugs that have been in short supply in recent years.
-
Serum Institute Selects ABEC for Large-Scale, Single-Use COVID-19 Vaccine Manufacturing
9/30/2020
ABEC , a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it is supporting Serum Institute of India Pvt. Ltd. (SIIPL) in Pune, India by delivering six 4,000L CSR bioreactors for the manufacturing of Novavax’ COVID-19 vaccine can
-
Foundation for Sarcoidosis Research Announces New CEO
9/30/2020
The Foundation for Sarcoidosis Research (FSR), the leading nonprofit organization dedicated to advancing research and improving care for individuals living with sarcoidosis, today announces Mary McGowan as the organization's first-ever Chief Executive Officer (CEO).
-
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19
9/30/2020
Sorrento to initiate testing with a selection of its agents in combination with ViralClear’s anti-viral compound for possible synergistic anti-viral effect against SARS-CoV-2 in the preclinical model of Golden Syrian hamster. ViralClear to contribute its oral antiviral merimepodib (IMPDH inhibitor) which is currently in a Phase 2 trial in combination with remdesivir to treat COVID-19. Sorrento to initially make available STI-1400 neutraliz
-
INVIVO Communications Joins Red Nucleus
9/30/2020
Red Nucleus ("RN"), a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired INVIVO Communications ("INVIVO"), a leading digital scientific communications agency.
-
Matrivax Appoints Dr. Enda Moran as Vice President of Process Development and CMC
9/30/2020
Matrivax Research and Development Corporation has named Enda Moran , PhD, MBA, as vice president of process development and CMC. Dr. Moran will lead process development, chemistry, manufacturing and controls for
-
Medidata Positioned as Leader in Everest Group’s “Clinical Development Platform Vendors” PEAK Matrix Assessment for Second Consecutive Year
9/30/2020
Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions to support the entire clinical development process, today announced that it has for the second year in a row been named a Leader in the “Clinical Development Platform Vendors PEAK Matrix® Assessment 2020” by Everest Group.
-
OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA
9/30/2020
-- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiro TM Cell-Free Cloning System, the world's first technology enabling cell-free amplification of large circular DNA, eliminating the reliance on E. coli cloning.
-
PhysIQ and Purdue University launch study to develop algorithms for detecting earliest signs of COVID-19 from biometric smartwatch data
9/30/2020
Certain changes in a person’s heart and breathing rates could precede symptoms of COVID-19, an increasing number of studies suggests. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005184/en/ Purdue University researchers are helping to develop physIQ software that could indicate that a person should get tested for COVID-19 by detecting s
-
Prestigious national pediatric medical device competition announces six winners to share in $250K NCC-PDI grant funding
9/30/2020
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces six awardees chosen in its annual "Make Your Medical Device Pitch for Kids!" competition to share in $250,000 in grants funded by the Food and Drug Administration (FDA) to support the advancement of pediatric medical devices.
-
DJO® Announces New Stemless Shoulder Offering – the AltiVate® Anatomic CS EDGE™
9/30/2020
DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the launch of the canal-sparing AltiVate® Anatomic CS EDGE™ Shoulder System. As the latest innovation from shoulder industry leader DJO®, the new system is designed to provide a more bone-sparing so